跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ambikacin
Approved
STANDARD
Ambikacin
Brawn Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ea1d8fdde5b65579
Company
Brawn Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
ea1d8fdde5b65579
Drug Approval Philippines Name
Ambikacin
Product Name
Ambikacin
Registration Number
DRP-4073-05
Brand Name
Ambikacin
Generic Name
Clarithromycin
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Brawn Laboratories Ltd.
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals Inc.
Issuance Date
24 March 2022
Expiry Date
24 October 2027
Pharmacologic Category
Antibacterial (Macrolide)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ea1d8fdde5b65579
Type
Standard
Back to Philippines FDA Approvals
Ambikacin - Philippines FDA Drug Approval Details